Royce & Associates’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.1M | Buy |
|
|||||
|
2025
Q2 | $34.3M | Sell |
|
|||||
|
2025
Q1 | $38.8M | Sell |
|
|||||
|
2024
Q4 | $38.9M | Sell |
|
|||||
|
2024
Q3 | $40.2M | Sell |
|
|||||
|
2024
Q2 | $33.5M | Buy |
|
|||||
|
2024
Q1 | $33.2M | Buy |
|
|||||
|
2023
Q4 | $29.3M | Buy |
|
|||||
|
2023
Q3 | $18.8M | Buy |
|
|||||
|
2023
Q2 | $14M | Buy |
|
|||||
|
2023
Q1 | $10.2M | Buy |
|
|||||
|
2022
Q4 | $9.89M | Sell |
|
|||||
|
2022
Q3 | $8.45M | Sell |
|
|||||
|
2022
Q2 | $14.7M | Sell |
|
|||||
|
2022
Q1 | $18.8M | Sell |
|
|||||
|
2021
Q4 | $17.5M | Sell |
|
|||||
|
2021
Q3 | $15.9M | Sell |
|
|||||
|
2021
Q2 | $17.7M | Sell |
|
|||||
|
2021
Q1 | $15M | Buy |
|
|||||
|
2020
Q4 | $8.03M | Buy |
|
|||||
|
2020
Q3 | $5.3M | Buy |
|
|||||
|
2020
Q2 | $6.05M | Buy |
|
|||||
|
2020
Q1 | $2.48M | Sell |
|
|||||
|
2019
Q4 | $2.93M | Buy |
|